Eli Lilly’s Lung Cancer Treatment Candidate Shows Strong Results in Trial

 

Eli Lilly’s Lung Cancer Treatment Candidate Shows Strong Results in Trial

Eli Lilly shares were gaining 1.72% to $116.01 in premarket trading Monday. Global stocks extended gains Monday, pulling U.S. equity futures into the green, as investors shifted focus from last week’s …

More Eli Lilly’s Lung Cancer Treatment Candidate Shows Strong Results in Trial Videos

Leave a Reply